Unilab picks Crush

Philippines - Pharmaceutical company Unilab has appointed TNBT's Crush Philippines to relaunch its Tuseran cough medicine.

Previously positioned as a cough medicine that also alleviated colds, headaches and fever, Tuseran will now be relaunched as a multi-cough medicine rather than a multi-ailment medicine.

Marco Nieto, managing director of Crush, said, "We are thrilled that Unilab has chosen to go with CRUSH's concept which hits their target market directly and ably communicates the brand's new message".

Crush will carry out BTL advertisements to help reinforce Tuseran's new positing as a multi-cough relief medicine, addressing the three most common cough symptoms, namely - itchy and painful throat and incessant coughing.

The BTL advertisements will run in 13 different areas around Luzon starting from 15 April till May this year.